Amy S Billing
Biographic Data
| ID | 6679384 |
|---|---|
| NAME | Amy S Billing |
| GIVEN NAMES | Amy S |
| FAMILY NAME | Billing |
| SIGNATURE | BILLING A S |
| AFFILIATIONS | University of Maryland, College Park |
| ORCID | 0000-0001-8068-1982 |
| VERIFIED | Yes |
| TOTAL WORKS | 6 |
| TOTAL CITATIONS | 1 |
| AUTHOR COUNT | 6 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 1 |
On the Value of Measuring Recent Drug Use by Self-Reports and Urinalysis in Clinical Trials
Background: Valid measurement of drug use in patients enrolled in clinical trials that treat substance use disorder is vital to determine the trial’s outcome. Self-reports are often used but their validity has been studied with mixed results. Urinalysis may sometimes be employed as an alternative or supplement to self-reports. Objectives: This study examined how estimating drug use by either method would affect the results from a randomized clini…
Spatial patterns of rural opioid-related hospital emergency department visits
Toward a National System of Expanded Testing of Existing Urine Specimens
BACKGROUND: NIDA's National Drug Early Warning System (NDEWS) was established in 2014 with the mission of identifying and monitoring emerging drugs in the United States. Identification of emerging drugs has been complicated, however, by the rapid development of novel psychoactive substances such that users often cannot identify and report the drugs they have ingested. Biologic testing of urine, hair or blood is the only way to reliably identify t…
Race-based differences in drug use prior to onset of opioid use disorder
Rates of opioid use disorder (OUD) have increased dramatically over the past two decades, a rise that has been accompanied by changing demographics of those affected. Early exposure to drugs is a known risk factor for later development of opioid use disorder; but how and whether this risk factor may differ between racial groups is unknown. Our study seeks to identify race differences in self-report of current and past substance use in OUD-diagnos…
Co-use of methamphetamine and opioids among people in treatment in Oregon
Using socially-sensed data to infer ZIP level characteristics for the spatiotemporal analysis of drug-related health problems in Maryland
Using socially-sensed data to infer ZIP level characteristics for the spatiotemporal analysis of drug-related health problems in Maryland
Toward a National System of Expanded Testing of Existing Urine Specimens
BACKGROUND: NIDA's National Drug Early Warning System (NDEWS) was established in 2014 with the mission of identifying and monitoring emerging drugs in the United States. Identification of emerging drugs has been complicated, however, by the rapid development of novel psychoactive substances such that users often cannot identify and report the drugs they have ingested. Biologic testing of urine, hair or blood is the only way to reliably identify t…
Race-based differences in drug use prior to onset of opioid use disorder
Rates of opioid use disorder (OUD) have increased dramatically over the past two decades, a rise that has been accompanied by changing demographics of those affected. Early exposure to drugs is a known risk factor for later development of opioid use disorder; but how and whether this risk factor may differ between racial groups is unknown. Our study seeks to identify race differences in self-report of current and past substance use in OUD-diagnos…
Co-use of methamphetamine and opioids among people in treatment in Oregon
On the Value of Measuring Recent Drug Use by Self-Reports and Urinalysis in Clinical Trials
Background: Valid measurement of drug use in patients enrolled in clinical trials that treat substance use disorder is vital to determine the trial’s outcome. Self-reports are often used but their validity has been studied with mixed results. Urinalysis may sometimes be employed as an alternative or supplement to self-reports. Objectives: This study examined how estimating drug use by either method would affect the results from a randomized clini…
Spatial patterns of rural opioid-related hospital emergency department visits
Medicine (6 works) · Psychiatry (4 works) · HIV, Drug Use, Sexual Risk (3 works) · Internal Medicine (3 works) · Opioid Use Disorder Treatment (3 works) · Psychology (3 works) · Substance Abuse Treatment and Outcomes (3 works) · Drug (2 works) · Emergency department (2 works) · Environmental health (2 works)